Author: Bousquet J. Yssel H. demoly P.
Publisher: Adis International
ISSN: 1173-8804
Source: BioDrugs, Vol.13, Iss.1, 2000-01, pp. : 61-75
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Spotlight on Omalizumab in Allergic Asthma
By Lynne M. Bang Greg L. Plosker
BioDrugs, Vol. 18, Iss. 6, 2004-01 ,pp. :
Prospects for a Vaccine for Clostridium difficile
By Kyne L.
BioDrugs, Vol. 10, Iss. 3, 1998-09 ,pp. :
Prospects for the Development of New Vaccine Adjuvants
By Cox J. Coulter A.
BioDrugs, Vol. 12, Iss. 6, 1999-12 ,pp. :
Respirable Antisense Oligonucleotide (RASON) Therapy for Allergic Asthma
By Metzger W.J.
BioDrugs, Vol. 12, Iss. 4, 1999-10 ,pp. :